{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:54:01Z","timestamp":1773334441289,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1991,9,1]]},"DOI":"10.1136\/hrt.66.3.250","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"250-255","source":"Crossref","is-referenced-by-count":35,"title":["British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction."],"prefix":"10.1136","volume":"66","author":[{"given":"R","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","article-title":"Hospital in-patient enquiry. Summary tables","year":"1984","unstructured":"Hospital in-patient enquiry. Summary tables. London: Department of Health and Social Security, 1984."},{"key":"ref_2","first-page":"397","article-title":"Gruppo Italiano per lo nell'Infarto miocardico Studio della Streptochinasi (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction","volume":"i:","year":"1986","unstructured":"Gruppo Italiano per lo nell'Infarto miocardico Studio della Streptochinasi (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.","journal-title":"Lancet"},{"key":"ref_3","first-page":"1088","article-title":"Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials","volume":"i:","author":"Yusuf, S.; Collins, R.; MacMahon, S.; Peto, R.","year":"1988","unstructured":"Yusuf S, Collins R, MacMahon S, Peto R. Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1988;i: 1088-92.","journal-title":"Lancet"},{"key":"ref_4","first-page":"98","article-title":"Reduction in major morbidity and mortality by heparin in acute myocardial infarction","volume":"78","author":"MacMahon, S.; Collins, R.; Knight, C.","year":"1988","unstructured":"MacMahon S, Collins R, Knight C, et al. Reduction in major morbidity and mortality by heparin in acute myocardial infarction [Abstract]. Circulation 1988;78:II-98.","journal-title":"Circulation"},{"key":"ref_5","first-page":"618","article-title":"Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet TIMI Study Group. Comparison 1988; i: 197-203. of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. NEngl JMed 1989; 320","author":"Simoons, M.L.; Arnold, A.E.R.; Betriu, A.","unstructured":"Simoons ML, Arnold AER, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet TIMI Study Group. Comparison 1988;i: 197-203. of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. NEngl JMed 1989;320:618-27."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198709033171001","article-title":"A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction","volume":"317","author":"Topol, E.J.; CaliffRM, George; B.S.","year":"1987","unstructured":"Topol EJ, CaliffRM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987;317:581-8.","journal-title":"N Engl J Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/bmj.289.6456.1431","article-title":"Beta-blockers after myocardial infarction: have trials changed practice?","volume":"289","author":"Baber, N.S.; Julian, D.G.; Lewis, J.A.; Rose, G.","year":"1984","unstructured":"Baber NS, Julian DG, Lewis JA, Rose G. Beta-blockers after myocardial infarction: have trials changed practice? BMJ 1984;289:1431-2.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/bmj.294.6582.1261","article-title":"Management of myocardial infarction in Scotland: have clinical trials changed practice?","volume":"294","author":"Hutchison, S.J.; Cobbe, S.M.","year":"1987","unstructured":"Hutchison SJ, Cobbe SM. Management of myocardial infarction in Scotland: have clinical trials changed practice? BMJ 1987;294:1261.","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/bmj.300.6719.237","article-title":"Districts' use of thrombolytic agents","volume":"300","author":"Burrell, C.J.; Skehan, J.D.; Cowley, M.L.; Barrett, C.W.; Mills, P.G.","year":"1990","unstructured":"Burrell CJ, Skehan JD, Cowley ML, Barrett CW, Mills PG. Districts' use of thrombolytic agents. BMJ 1990;300: 237-8.","journal-title":"BMJ"},{"key":"ref_10","first-page":"116","article-title":"for the ISIS Trials Collaborative Group. Drug treatment in hospital and at discharge in the ISIS-1 and ISIS-2 trials","volume":"1","author":"Wilhelmsen, L.; Collins, R.; Peto, R.; Sleight, P.","year":"1989","unstructured":"Wilhelmsen L, Collins R, Peto R, Sleight P for the ISIS Trials Collaborative Group. Drug treatment in hospital and at discharge in the ISIS-1 and ISIS-2 trials [abstract]. Eur Heart J 1989;1O(abstract suppl): 116.","journal-title":"Eur Heart J"},{"key":"ref_11","first-page":"\"515","article-title":"Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987","volume":"61","author":"Hlatky, M.A.; Cotugno, H.E.; Mark, D.B.","year":"1988","unstructured":"Hlatky MA, Cotugno HE, Mark DB, et al. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am JCardiol 1988;61:515-8., 20 Hlatky MA, Cotugno H, O'Connor C, et al. Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol 1988;61:510-4.","journal-title":"Am JCardiol; Adoption of thrombolytic therapy in the management of acute myocardial infarction"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.eurheartj.a061905","article-title":"Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials","volume":"6","author":"Yusuf, S.; Collins, R.; Peto, R.","year":"1985","unstructured":"Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-85.","journal-title":"Eur Heart J"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/sim.4780030421","article-title":"Why do we need some large, simple randomized trials?","volume":"3","author":"Yusuf, S.; Collins, R.; Peto, R.","year":"1984","unstructured":"Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984;3:409-20.","journal-title":"Stat Med"},{"key":"ref_14","first-page":"421","article-title":"Streptokinase in acute myocardial infarction","volume":"i:","year":"1986","unstructured":"Streptokinase in acute myocardial infarction. Lancet 1986;i:421-2.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf, S.; Peto, R.; Lewis, R.; Collins, R.; Sleight, P.","year":"1985","unstructured":"Yusuf S, Peto R, Lewis R, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.","journal-title":"Prog Cardiovasc Dis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/sim.4780060308","article-title":"Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews","volume":"6","author":"Collins, R.; Gray, R.; Godwin, J.; Peto, R.","year":"1987","unstructured":"Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 1987;6:245-50.","journal-title":"Stat Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.66.3.250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:08:17Z","timestamp":1601082497000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.66.3.250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9,1]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.66.3.250","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1991,9,1]]}}}